Pharmaceutical formulation
Fe(II) supplement (Ferro-Gradumet, Abbot Laboratories, UK) was examined for Fe(III) content. According to the producer, the product contained 325 mg of Fe(II) sulphate [105 mg of Fe(II)] per tablet.
Apparatus
Absorbance was measured and absorption spectra were recorded using a JASCO V-560 (Japan) UV-VIS spectrophotometer. Quartz cells (l = 1 cm) were used.
Procedure
To the test solution containing not more than 150 µg Fe(III) and 45 mg Fe(II), the following were subsequently added: 1.2 mL of 1´10 -3 mol L -1 quercetin (or 1.4 mL of 11 0 -3 mol L -1 morin), 3 mL of methanol and hydrochloric acid in such amount so as to obtain a final 10-mL volume of 0.3 mol L -1 HCl. The sample was diluted to 10-mL with 0.01 mol L -1 HCl and heated at 70°C for 20 min. The solution was cooled and its volume was adjusted to 10-mL with 0.3 mol L -1 HCl in case of evaporation. Fe(III) concentration was determined using absorbance at 291 nm (quercetin method) and 293 nm (morin method) and the appropriate regression equation.
RESULTS AND DISCUSSION

Reaction of Fe(III) with quercetin
The experiments have shown that both redox and complexation reactions can simultaneously occur in solutions containing Fe(III) in hydrochloric acid medium and quercetin. Aqueous-methanolic (3:2) solutions were used because of limited solubility of quercetin in pure water. Formation of two species exhibiting absorption bands in visible and UV regions (Fig. 2a -curves 3 and 3' , respectively) has been observed. The absorption band in the visible region is characteristic of the complex of the metal ion with the reagent. Maximum absorbance of the complex of Fe(III) with quercetin occurs at l max = 422.5 nm. The second absorption band in the 260-340 nm region is characteristic of the oxidized form of the reagent. Similar absorption bands, identified as characteristic of quinone derived from the flavonoid compounds used, were observed earlier in the other systems containing quercetin and morin and metal ions of oxidizing properties, Ru(IV), Au(III) and Os(VIII) (9, 11, 12) .
Equilibrium of both complexation and redox reactions, as well as the amount of particular species formed depend on the conditions applied: hydrochloric acid concentration, reaction time and temperature. Lower acid concentrations are favourable for formation of the Fe(III)-quercetin complex. Increase in HCl concentration in the solution containing the complex results in shifting the equilibrium into the redox process and quantitative formation of the final oxidized form of quercetin (quinone) with l max at 291 nm ( Fig. 2a -curve 4) . Optimum HCl concentrations for the formation of the complex and product of the redox reaction amount to 0.03 mol L -1 and 0.3 mol L -1 , respectively.
In our experiments we observed low stability of the Fe(III) complex with quercetin. Rapid decrease (ca. 98% within 1 h) of its absorbance was recorded ( Fig. 3 -curve 1) . Simultaneous increase in the amount of species with l max at 291 nm was observed ( Fig. 3 -curve 2 ). This confirms the occurrence of the redox reaction between Fe(III) and quercetin with time. The process can be significantly accelerated by heating the solution. Quantitative formation of the redox reaction product and complete decomposition of the complex was observed after 15 min of heating at 70°C. Longer heating time under the conditions used has no effect on the equilibrium of the reaction examined.
The (Table 1) . Under the optimum conditions for Fe(III) determination, no redox or complexation reaction of Fe(II) with the reagent was observed. We did not observe any interference of Fe(II) with Fe(III) detection up to 300-fold mass excess of Fe(II) to Fe(III) examined in the work. As a consequence, we have drawn the conclusion that the redox reaction occurring in the Fe(III)-quercetin system can serve as the basis for a selective spectrophotometric method for Fe(III) in the presence of Fe(II) ions. a Mean ± SD (n = 6).
Reaction of Fe(III) with morin
The experiments have shown that morin (Fig. 2b) reacts very similarly to quercetin with Fe(III) ions. Also, the complexation and redox reactions occur in methanolic-aqueous solutions containing Fe(III) and the reagent. Equilibrium between the reaction products mainly depends on the hydrochloric acid concentration in the examined samples. Shifting to the formation of the Fe(III) complex with morin in less acidic media (0.03 mol L -1 HCl as optimal) (Fig. 2b -curve 3) and to the redox reaction product in solutions of higher HCl concentration (Fig. 2b -curve 4) (Table I) .
Similarly as in the case of quercetin, no interaction of Fe(II) with morin was observed under the conditions applied. Large amounts of Fe(II) ions (300-fold mass excess of Fe(II) over Fe(III) examined) did not affect the reaction of Fe(III) with morin.
Determination of Fe(III) in a Fe(II) pharmaceutical formulation
The redox reaction occurring between Fe(III) and quercetin was applied to the determination of Fe(III) in a Fe(II) pharmaceutical product used as an iron supplement for humans. Small amounts of Fe(III) in such products can originate from the oxidation of Fe(II) by air oxygen. Quercetin method was chosen for the determination because of its lower limit of detection.
The tablets (five tablets were taken for analysis) were preliminarily treated with methanol (5 mL for 5 min) to eliminate the protective external layer containing polymeric additives and pigments. After separation of the methanolic extract, the tablets were treated with 5 mL 1 mol L -1 HCl. After 20 min, the samples were filtered into a 10-mL volumetric flasks and the obtained solution was diluted to the final volume with 1 mol L -1 HCl. The content of Fe(III) was determined in an aligment of 2 mL. The amount of Fe(III) was in the range of 0.210-0.262 mg per tablet (0.234 ± 0.021 mg, n = 6). RSD of the results equaled 9.1%. The amount of Fe(III) determined in the Fe(II) supplement examined was ca. 0.2% per tablet. The accuracy of the results was evaluated by the standard addition method. The spike of the standard solution of Fe(III) was introduced into the
